Symbol="PBYI"
AssetType="Common Stock"
Name="Puma Biotechnology Inc"
Description="Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to improve cancer care in the United States and internationally. The company is headquartered in Los Angeles, California."
CIK="1401667"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="10880 WILSHIRE BLVD., SUITE 2150, LOS ANGELES, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="154600000"
EBITDA="45173000"
PERatio="30.09"
PEGRatio="0.03"
BookValue="0.554"
DividendPerShare="0"
DividendYield="0"
EPS="0.11"
RevenuePerShareTTM="5.13"
ProfitMargin="0.0204"
OperatingMarginTTM="0.152"
ReturnOnAssetsTTM="0.113"
ReturnOnEquityTTM="0.291"
RevenueTTM="235070000"
GrossProfitTTM="172938000"
DilutedEPSTTM="0.11"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.154"
AnalystTargetPrice="4.75"
TrailingPE="30.09"
ForwardPE="11.29"
PriceToSalesRatioTTM="1.045"
PriceToBookRatio="9.06"
EVToRevenue="1.092"
EVToEBITDA="7.87"
Beta="1.048"
num_52WeekHigh="5.16"
num_52WeekLow="2.08"
num_50DayMovingAverage="3.296"
num_200DayMovingAverage="3.426"
SharesOutstanding="46707000"
DividendDate="None"
ExDividendDate="None"
symbol="PBYI"
open="3.28"
high="3.40"
low="3.27"
price="3.34"
volume="107151.00"
latest_trading_day="2023-07-19"
previous_close="3.31"
change="0.03"
change_percent="0.9063%"
aroon_positive_momentum_days="34"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="34"
Volume_recent_avg="280032"
Change_recent_avg="-0.01"
Delta_recent_avg="0.19"
Variance_recent_avg="0.1"
Change_ratio_recent_avg="-0.38"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="34"
Aroon_momentum_negative="66"
image_negative_thumbnail_id_1="493"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0112.jpeg"
image_negative_thumbnail_id_2="171"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0005.jpeg"
image_neutral_thumbnail_id_1="526"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0073.jpeg"
image_neutral_thumbnail_id_2="432"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Neutral_Landscape_0019.jpeg"
image_positive_thumbnail_id_1="701"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0007.jpeg"
image_positive_thumbnail_id_2="1001"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0163.jpeg"
image_professor_thumbnail_id_1="1176"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
image_professor_thumbnail_id_2="1182"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0016.jpeg"
